Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt/β-catenin signaling pathway
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Chronic stress is one of the major causes that lead to major depressive disorder, which is a prevalent mood disorder worldwide. Many patients with major depressive disorder do not benefit from available medication due to the complex etiology of the condition. Recently, long non-coding RNAs, molecular switches of downstream genes expression, have been reported to be involved in the pathogenesis of major depressive disorder. The long non-coding RNA TCONS_00019174 has been implicated in major depressive disorder risk and antidepressant effects, However, the effect of long non-coding RNA TCONS_00019174 on antidepressant responses has not been investigated. This study is designed to determine whether altered expression of long non-coding RNA TCONS_00019174 contributes to depression-like behaviors associated with chronic stress. We found that mice exposed to chronic ultra-mild stress displayed apparent depression-like behaviors and decreased expression of long non-coding RNA TCONS_00019174 in hippocampus. Both changed behaviors and long non-coding RNA TCONS_00019174 expression level were rescued by chronic treatment with imipramine. Viral-mediated long non-coding RNA TCONS_00019174 overexpression in hippocampal neurons improved the behaviors of mice exposed to chronic ultra-mild stress. Further, it was found long non-coding RNA TCONS_00019174 overexpression upregulated phosphorylated-GSK3$\beta$(p-GSK3$\beta$) protein and $\beta$-catenin in the hippocampus. These findings suggest that long non-coding RNA TCONS_00019174 exerts antidepressant-like effect in mice by activating a Wnt/$\beta$-catenin pathway, and that long non-coding RNA may serve as a potential therapeutic target for major depressive disorder in clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“Stress is a potent negative factor that can lead to psychiatric disease such as depression and anxiety disorders [1, 2].”
BackgroundMechanisms of stress in the brain
McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., Karatsoreos, I. N., & Nasca, C. (2015) · Nature Neuroscience · doi:10.1038/nn.4086 · Cited by 1,386
Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the Nucleus
Peifer, M., & Polakis, P. (2000) · Science · doi:10.1126/science.287.5458.1606 · Cited by 1,253 · cited 1×
“β -catenin, a substrate of GSK-3β [40], has been implicated in brain development and growth [41].”
BackgroundLong-term depression in the CNS
Collingridge, G. L., Peineau, S., Howland, J. G., & Wang, Y. T. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2867 · Cited by 926
Determining the role of microRNAs in psychiatric disorders
Issler, O., & Chen, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3879 · Cited by 309
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · cited 1×
“Enhancement of GSK-3β activity helps to reduce synaptic spine density in response to stress [1, 36] and patients with MDD have increased GSK-3β activity [37].”
BackgroundEpigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277 · cited 1×
“Recent research has reported that either the environment or behavior could cause epigenetic changes at specific gene loci, such as dysregulated transcription of genes expression, contributing to the pathogenesis of depression [10].”
BackgroundNeighborhood matters: divergent patterns of stress-induced plasticity across the brain
Chattarji, S., Tomar, A., Suvrathan, A., Ghosh, S., & Rahman, M. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4115 · Cited by 248
Wan, Y., Liu, Y., Wang, X., Wu, J., Liu, K., Zhou, J., Liu, L., & Zhang, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121975 · Cited by 182 · cited 1×
“miRNAs (miR-16) [30, 31], miR-221-3p, miR-34a-5p, let-7d-3p, and miR-451a [32], miRNA-26b, miRNA-1972, miRNA-4743, miRNA4498, and miRNA-4485 [33] were found to be involved in the occurrence and development of MDD, and changes of miRNAs expression have been closely associated with the improvement of MDD symptoms [34, 3…”
BackgroundEmerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention
Hendrickx, H., McEwen, B. S., & Ouderaa, F. V. D. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.005 · Cited by 83
Numata, S., Ishii, K., Tajima, A., Iga, J.-I., Kinoshita, M., Watanabe, S., Umehara, H., Fuchikami, M., Okada, S., Boku, S., et al. (2015) · Epigenetics · doi:10.1080/15592294.2014.1003743 · Cited by 79
Research works printed but not linked: 31
- Krishnan V, Nestler EJ ( 2008) The molecular neurobiology of depression. Nature 455(7215), 894-902. · DOI · Paper page
- Franklin TB, Saab BJ, Mansuy IM ( 2012) Neural mechanisms of stress resilience and vulnerability. Neuron 75(5), 747-761. · DOI · Paper page
- Im HI, Kenny PJ ( 2012) MicroRNAs in neuronal function and dysfunction. Trends in Neurosciences 35(5), 325-334. · DOI · Paper page
- Schmidt HD, Shelton RC, Duman RS ( 2011) Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 36(12), 2375-2394. · DOI · Paper page
- Oquendo MA, McGrath P, Weissman MM ( 2014) Biomarker studies and the future of personalized treatment for depression. Depression and Anxiety 31(11), 902-905. · DOI
- Bartel DP ( 2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233. · DOI · Paper page
- Kosik KS ( 2006) The neuronal microRNA system. Nature Reviews Neuroscience 7(12), 911-920. · DOI · Paper page
- Geaghan M, Cairns MJ ( 2015) MicroRNA and posttranscriptional dysregulation in psychiatry. Biological Psychiatry 78(4), 231-239. · DOI · Paper page
- Kocerha J, Dwivedi Y, Brennand KJ ( 2015) Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease. Molecular Psychiatry 20(6), 677-684. · DOI · Paper page
- O'connor R, Dinan T, Cryan J ( 2012) Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Molecular Psychiatry 17(4), 359-376. · DOI
- Ponjavic J, Oliver PL, Lunter G, Ponting CP ( 2009) Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLos Genetics 5(8), e1000617. · DOI · Paper page
- Yang F, Zhang L, Huo XS, Yuan Jh, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ ( 2011) Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54(5), 1679-1689. · DOI · Paper page
- Cui X, Sun X, Niu W, Kong L, He M, Zhong A, Chen S, Jiang K, Zhang L, Cheng Z ( 2016) Long non-coding RNA: Potential diagnostic and therapeutic biomarker for major depressive disorder. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 22, 5240-5248. · DOI · Paper page
- Voleti B, Duman R ( 2012) The roles of neurotrophic factor and Wntsignaling in depression. Clinical Pharmacology & Therapeutics 91(2), 333-338. · DOI · Paper page
- Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H ( 2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on b-catenin in mouse hippocampus. Biological Psychiatry 55(8), 781-784. · DOI · Paper page
- Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, Suzuki T, Miyata N, Watanabe Y ( 2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69(2), 359-372. · DOI · Paper page
- Uchida S, Hara K, Kobayashi A, Fujimoto M, Otsuki K, Yamagata H, Hobara T, Abe N, Higuchi F, Shibata T ( 2011) Impaired hippocampal spinogenesis and neurogenesis and altered affective behavior in mice lacking heat shock factor 1. Proceedings of the National Academy of Sciences of the United States of America 108(4), 1681-1684. · DOI · Paper page
- Seibenhener ML Wooten MW, ( 2012) Isolation and culture of hippocampal neurons from prenatal mice. Journal of Visualized Experiments 65(65), e3634 . · doi:10.3791/3634-v · Paper page
- David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP ( 2009) Neurogenesisdependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62(4), 479-493. · DOI · Paper page
- Porsolt R, Bertin A, Jalfre M ( 1977) Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229(2), 327-336.
- Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O ( 2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634), 805-809. · DOI · Paper page
- Kuss AW, Chen W ( 2008) MicroRNAs in brain function and disease. Current Neurology and Neuroscience Reports 8(3), 190-197. · DOI · Paper page
- Song MF, Dong JZ, Wang YW, He J, Ju X, Zhang L, Zhang YH, Shi JF, Lv YY ( 2015) CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system. Journal of Affective Disorders 178, 25-31. · DOI
- Fan HM, Sun XY, Guo W, Zhong AF, Niu W, Zhao L, Dai YH, Guo ZM, Zhang LY, Lu J ( 2014) Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients. Journal of Psychiatric Research 59, 45-52. · DOI
- Song HT, Sun XY, Zhang L, Zhao L, Guo ZM, Fan HM, Zhong AF, Niu W, Dai YH, Zhang LY ( 2014) A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment. Journal of Psychiatric Research 54, 134-140. · DOI
- Sun XY, Lu J, Zhang L, Song HT, Zhao L, Fan HM, Zhong AF, Niu W, Guo ZM, Dai YH ( 2015) Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. Journal of Clinical Neuroscience 22(3), 570-574. · DOI
- Jope RS, Roh MS ( 2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Current Drug Targets 7(11), 1421-1434. · DOI · Paper page
- Ge JF, Peng YY, Qi CC, Chen FH, Zhou JN ( 2014) Depression-like behavior in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocrine 45( 3), 430-438. · DOI
- Yu X, Malenka RC ( 2003) b-catenin is critical for dendritic morphogenesis. Nature Neuroscience 6(11), 1169-1177. · DOI · Paper page
- Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R, Malafosse A ( 2012) Protein levels ofβ-catenin and activation state of glycogen synthase kinase-3β in major depression. A study with postmortem prefrontal cortex. Journal of Affective Disorders 136(1, 2), 185-188. · DOI
- Pilar-CuÉllar F, Vidal R, Pazos A ( 2012) Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, b-catenin and antidepressant-like effects. British Journal of Pharmacology 165(4b), 1046-1057. · DOI · Paper page
Cited by
Yuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
“Furthermore, viral-mediated overexpression of lncRNA TCONS 00019174 aggravated depression status in depressed mice model, indicating that lncRNA TCONS 00019174 may be linked to the pathogenesis of depression.(313) Differentially expressed lncRNAs showed correlations with 18 synapse-related functions, which showed that…”
BackgroundMao, J., Li, T., Fan, D., Zhou, H., Feng, J., Liu, L., Zhang, C., & Wang, X. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2374-2 · Cited by 120
Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
Shi, Y., Wang, Q., Song, R., Kong, Y., & Zhang, Z. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103569 · Cited by 79
Kahl, K. G., Stapel, B., & Frieling, H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.004 · Cited by 47
Emerging roles of long non-coding RNA in depression
Hao, W.-Z., Chen, Q., Wang, L., Tao, G., Gan, H., Deng, L.-J., Huang, J.-Q., & Chen, J.-X. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110515 · Cited by 37
Metadata
- Authors
- Ni, X., Liao, Y., Li, L., Zhang, X., & Wu, Z.
- Venue
- Journal of Integrative Neuroscience
- Publisher
- IMR Press
- Published
- 2018-05-15
- Volume
- 17
- Issue
- 2
- Pages
- 125-132
- ISSN
- 0219-6352 (ISSN-L)
- 1757-448X
- OpenAlex
- W2761510811
- Cited by
- 37
- References
- 12
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.